Abstract
Viral vectors are valuable tools to deliver genetic materials into cells. Vectors derived from human immunodeficiency virus type 1 are being widely used for gene delivery, mainly because they are able to transduce both dividing and non-dividing cells which leads to stable and long term gene expression. In addition, these types of vectors are safe, with low toxicity, high stability and cell type specificity. Therefore, this work was aimed to produce lentivirus-based vector using a three-plasmid system. To produce this system, the eGFP marker gene was cloned into the plasmid pWPXLd. Subsequently, this vector plasmid, along with packaging plasmids, psPAX2 and envelope plasmid, pMD2.G, was co-transfected into packaging cell line (293T) using calcium phosphate method. 48 h post transfection, the constructed viral vector was harvested, purified and concentrated and stored at −80 °C for next experiments. The titration of the vector was carried out, using ELISA, flowcytometry, and fluorescent microscopy. Finally, transduction of HEK-293T, CHO, HepG2, MCF-7, MEFs and Jurkat cell lines was carried out with indicated cell numbers and multiplicities of infections of the vector in the presence of polybrene. Using this system, high titer lentivirus at titers of up to 2 × 108 transducing units/ml (TU/ml) was successfully generated and its transduction efficacy was improved by seven to over 20-fold in various cell types. We demonstrate the applicability of this vector for the efficient transduction of dividing and non-dividing cells, including HEK-293T, CHO, HepG2, MCF-7, MEFs and Jurkat cell line. Transduction efficiency yielded titers of (6.3 ± 1.2) 105 TU/ml. Furthermore, lentivirus transferred transgene was expressed at high level in the target cells and expression was followed until 90 days after transduction. Thus, the vector generated in this work, might be able to deliver the transgene into a wide range of mammalian cells.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bartz SR, Vodicka MA (1997) Production of high-titer human immunodeficiency virus type 1 pseudotyped with vesicular stomatitis virus glycoprotein. Methods 12:337–342
Bartz SR, Rogel ME, Emerman M (1996) Human immunodeficiency virus type 1 cell cycle control: Vpr is cytostatic and mediates G2 accumulation by a mechanism which differs from DNA damage checkpoint control. J Virol 70:2324–2331
Burns JC, Friedmann T, Driever W, Burrascano M, Yee JK (1993) Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. Proc Natl Acad Sci USA 90:8033–8037
Follenzi A, Naldini L (2002) HIV-based vectors. In Morgan JR (ed) Gene therapy protocols. Humana Press, pp 259–274. http://link.springer.com/protocol/10.1385%2F1-59259-141-8%3A259
Kafri T, van Praag H, Ouyang L, Gage FH, Verma IM (1999) A packaging cell line for lentivirus vectors. J Virol 73:576–584
Konvalinka J et al (1995) An active-site mutation in the human immunodeficiency virus type 1 proteinase (PR) causes reduced PR activity and loss of PR-mediated cytotoxicity without apparent effect on virus maturation and infectivity. J Virol 69:7180–7186
Li C, Friedman D, Wang C, Metelev V, Pardee A (1995) Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein. Science 268:429–431
Liao W, Ning G (2006) Knockdown of apolipoprotein B, an atherogenic apolipoprotein, in HepG2 cells by lentivirus-mediated siRNA. Biochem Biophys Res Commun 344:478–483
Miyazaki Y, Takamatsu T, Nosaka T, Fujita S, Martin TE, Hatanaka M (1995) The cytotoxicity of human immunodeficiency virus type 1 Rev: implications for its interaction with the nucleolar protein B23. Exp Cell Res 219:93–101
Naldini L, Blömer U, Gallay P, Ory D, Mulligan R, Gage FH (1996) In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272:263–267
Pham L, Ye H, Cosset F-L, Russell SJ, Peng K-W (2001) Concentration of viral vectors by co-precipitation with calcium phosphate. J Gene Med 3:188–194
Reiser J (2000) Production and concentration of pseudotyped HIV-1-based gene transfer vectors, vol 7. Nature Publishing Group, London, UK
Reiser J, Harmison G, Kluepfel-Stahl S, Brady RO, Karlsson S, Schubert M (1996) Transduction of nondividing cells using pseudotyped defective high-titer HIV type 1 particles. Proc Natl Acad Sci USA 93:15266–15271
Salmon P, Trono D (2001) Production and titration of lentiviral vectors. In: Current protocols in human genetics. Wiley. doi:10.1002/0471142905.hg1210s54/otherversions
Segura M, Garnier A, Durocher Y, Ansorge S, Kamen A (2010) New protocol for lentiviral vector mass production. In: Federico M (ed) Lentivirus gene engineering protocols. Humana Press, pp 39–52. doi:10.1007/978-1-60761-533-0_2
Sena-Esteves M, Tebbets JC, Steffens S, Crombleholme T, Flake AW (2004) Optimized large-scale production of high titer lentivirus vector pseudotypes. J Virol Methods 122:131–139
Tiscornia G, Singer O, Verma IM (2006) Production and purification of lentiviral vectors. Nat Protocols 1:241–245
VandenDriessche T, Naldini L, Collen D, Chuah MK (2002) Oncoretroviral and lentiviral vector-mediated gene therapy. Methods Enzymol 346:573–589
Zhang B, Xia Q, Cleghorn G (2001) A highly efficient and consistent method for harvesting large volumes of high-titre lentiviral vectors, vol 8. Nature Publishing Group, London, ROYAUME-UNI
Zimmermann K, Scheibe O, Kocourek A, Muelich J, Jurkiewicz E, Pfeifer A (2011) Highly efficient concentration of lenti- and retroviral vector preparations by membrane adsorbers and ultrafiltration. BMC Biotechnol 11:55
Acknowledgments
The authors would like to deeply appreciate Professor M.J. Rasaee (Tarbiat Modares University, Iran), Professor D. Trono (Ecole Polytechnique Fédérale de Lausanne, Switzerland) and Mrs. Severine Reynard (Ecole Polytechnique Fédérale de Lausanne, Switzerland).
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Nasri, M., Karimi, A. & Allahbakhshian Farsani, M. Production, purification and titration of a lentivirus-based vector for gene delivery purposes. Cytotechnology 66, 1031–1038 (2014). https://doi.org/10.1007/s10616-013-9652-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10616-013-9652-5